OTC Markets EXMKT - Delayed Quote USD
Transgene SA (TRGNF)
0.7000
0.0000
(0.00%)
At close: April 22 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 6.7M | 6.7M |
| Low Estimate | -- | -- | 6.7M | 6.7M |
| High Estimate | -- | -- | 6.7M | 6.7M |
| Year Ago Sales | -- | -- | 6.35M | 6.7M |
| Sales Growth (year/est) | -- | -- | 5.46% | 0.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| TRGNF | -- | -- | -- | -- |
| S&P 500 | 7.01% | 4.85% | 8.55% | 14.15% |
Related Tickers
VTVT vTv Therapeutics Inc.
19.89
+1.69%
LVTX LAVA Therapeutics N.V.
1.3800
-0.72%
SYRS Syros Pharmaceuticals, Inc.
0.0265
-8.30%
MGNX MacroGenics, Inc.
1.5200
+9.35%
NUVB Nuvation Bio Inc.
2.0600
+4.04%
NKTR Nektar Therapeutics
0.6640
+6.09%
FDMT 4D Molecular Therapeutics, Inc.
3.4000
+10.39%
CTMX CytomX Therapeutics, Inc.
0.7361
-1.84%
CHRS Coherus BioSciences, Inc.
1.0900
+2.83%
SGMO Sangamo Therapeutics, Inc.
0.7763
+5.48%